Therapeutic effects of recombinant human epidermal growth factor (rhEGF) in a murine model of concurrent chemo- and radiotherapy-induced oral mucositis 2015-03-19 cgbio 조회수Views : 984 Ryu SH, Kang KM, Moon SY, et al. Therapeutic effects of recombinant human epidermal growth factor (rhEGF) in a murine model of concurrent chemo- and radiotherapy-induced oral mucositis. J Radiat Res 2010; 51(5): 595-601. 다음글The preventive effect of recombinant human growth factor (rhEGF) on the recurrence of radiodermatitis 이전글Early recombinant human epidermal growth factor treatment recovers the irradiation-induced decrease of Na+ absorption prior to the definite histological mucositis
